United Therapeutics (UTH) Revenue
United Therapeutics Revenue
United Therapeutics had a revenue of 783.30M in the quarter ending Jun 30, 2026, with 0.23%. This bring the company's revenue in the last twelve months to 3.15B, Decreased 0.48%. In the fiscal year ending Dec 31, 2025, United Therapeutics had annual revenue of 3.18B with 10.61% growth.
- Revenue (ttm)
- 3.15B
- Revenue Growth
- -4.46%
- P/S Ratio
- 7.20
- Revenue/Employee
- EUR 2,273,357
- Employees
- 1,400
- Market Cap
- EUR 22.92B
Revenue Chart
United Therapeutics Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.18B | 305.30M | 10.61% |
| Dec 31, 2024 | 2.88B | 549.90M | 23.63% |
| Dec 31, 2023 | 2.33B | 391.20M | 20.20% |
| Dec 31, 2022 | 1.94B | 250.80M | 14.88% |
| Dec 31, 2021 | 1.69B | 202.20M | 13.63% |
| Dec 31, 2020 | 1.48B | 34.50M | 2.38% |
| Dec 31, 2019 | 1.45B | -179.00M | -11.00% |
| Dec 31, 2018 | 1.63B | -97.50M | -5.65% |
| Dec 31, 2017 | 1.73B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.